EP4294367A4
Non-aqueous injectable composition for sustained release of buprenorphine and use thereof
Abstract
This record has no abstract on file.
Term
15.4 yearsto projected expiry
Projected expiry 16 February 2042, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US10022367B2 | Cites | United States of America | Search report |
| CN109010255A | Cites | China | Search report |
| US2018256496A1 | Cites | United States of America | Search report |
| WO2019144079A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| US8975270B2 | Cites | United States of America | Search report |
| See also references of WO 2022175974A1 | Non-patent | – | Search report |
9 members in 6 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 202121006827 | India | – | |
| 202121006827 | India | A | |
| 2022050133 | India | W |
Members9
| Document | Office | Kind | |
|---|---|---|---|
| CA3211413A1 | Canada | A1 | |
| WO2022175974A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2022222600A1 | Australia | A1 | |
| GB202313084D0 | United Kingdom | D0 | |
| GB2618507A | United Kingdom | A | |
| EP4294367A1 | European Patent Office (EPO) | A1 | |
| US2024139145A1 | United States of America | A1 | |
| EP4294367A4This record | European Patent Office (EPO) | A4 | |
| GB2618507B | United Kingdom | B |
18 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| First examination report despatched17Q | 17Q | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: EXAMINATION IS IN PROGRESSSTAA | STAA | |
| Supplementary search report drawn up and despatchedA4 | A4 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Request for validation of the european patent (deleted)DAV | DAV | |
| Request for extension of the european patent (deleted)DAX | DAX | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: REQUEST FOR EXAMINATION WAS MADESTAA | STAA | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADESTAA | STAA |
Numbers
- Publication
- 4294367
- Application
- 227557253
Titles3
- German
- NICHTWÄSSRIGE INJIZIERBARE ZUSAMMENSETZUNG ZUR VERZÖGERTEN FREISETZUNG VON BUPRENORPHIN UND VERWENDUNG DAVON
- English
- NON-AQUEOUS INJECTABLE COMPOSITION FOR SUSTAINED RELEASE OF BUPRENORPHINE AND USE THEREOF
- French
- COMPOSITION INJECTABLE NON AQUEUSE POUR LIBÉRATION PROLONGÉE DE BUPRÉNORPHINE ET SON UTILISATION
Classification
- CPC, 10
- A61K31/485
- A61K9/0019
- A61K31/33
- A61P25/04
- A61K47/10
- A61K47/12
- A61K47/14
- A61K47/24
- A61P29/00
- A61K47/34
- IPC, 8
- A61K9 00
- A61K31 4748
- A61K31 485
- A61K47 10
- A61K47 12
- A61K47 14
- A61K47 24
- A61P25 04
Designated states1
- Contracting states, 1
- Türkiye